Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fespixon in Scar Cosmesis Following Cervical or Abdominal Surgery
NCT05271708Phase 4Completed
- Sponsor
- National Defense Medical Center
- Start
- Jan 2022
- Primary completion
- Oct 2022
- Modality
- Botanical drug
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in scar comparing Fespixon cream with Placebo Cream (2 arms). Primary endpoint: Vancouver Scar Scale total scores at Week 12. Started Jan 2022; status: completed.
02
Drugs
Fespixon
03
Conditions
scar
Beyond the preview
Go deeper on NCT05271708.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05271708.